We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+2.2%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$4.12B
AUM Growth
-$54.3M
Cap. Flow
+$518K
Cap. Flow %
0.01%
Top 10 Hldgs %
6.44%
Holding
1,475
New
99
Increased
592
Reduced
300
Closed
114

Top Buys

Rank Stock Value
1
VIR icon
Vir Biotechnology
VIR
+$19.2M
2
ORCL icon
Oracle
ORCL
+$12.4M
3
CRGY icon
Crescent Energy
CRGY
+$11.4M
4
PARR icon
Par Pacific Holdings
PARR
+$11.1M
5
GPOR icon
Gulfport Energy Corp
GPOR
+$10.9M

Top Sells

Rank Stock Value
1
BCC icon
Boise Cascade
BCC
+$17.7M
2
THS
Treehouse Foods
THS
+$11.5M
3
TPH
Tri Pointe Homes
TPH
+$10.5M
4
STRL icon
Sterling Infrastructure
STRL
+$9.81M
5
TXN icon
Texas Instruments
TXN
+$9.45M

Sector Composition

Rank Sector Weight
1 Financials 25.32%
2 Consumer Discretionary 11.88%
3 Industrials 11.76%
4 Technology 10.68%
5 Energy 10.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RRGB icon
976
Red Robin
RRGB
$152M
$350K 0.01%
43,500
+10,000
+30% +$119K
FDMT icon
977
4D Molecular Therapeutics
FDMT
$562M
$349K 0.01%
27,400
– –
APEI icon
978
American Public Education
APEI
$940M
$347K 0.01%
69,600
– –
VOR icon
979
Vor Biopharma
VOR
$1.28B
$345K 0.01%
8,135
+3,125
+62% +$169K
PRAX icon
980
Praxis Precision Medicines
PRAX
$10.1B
$345K 0.01%
13,447
+6,667
+98% +$126K
VIRC icon
981
Virco
VIRC
$96.3M
$345K 0.01%
43,400
– –
ALT icon
982
Altimmune
ALT
$599M
$342K 0.01%
131,700
– –
ACCS
983
ACCESS Newswire
ACCS
$26.2M
$342K 0.01%
18,168
– –
ACET icon
984
Adicet Bio
ACET
$74.7M
$341K 0.01%
+15,575
New +$550K
WLDN icon
985
Willdan Group
WLDN
$1.3B
$341K 0.01%
16,700
– –
FLNT
986
Fluent
FLNT
$120M
$341K 0.01%
127,883
+3,581
+3% +$13.4K
HYPR icon
987
Hyperfine
HYPR
$101M
$337K 0.01%
164,400
+34,900
+27% +$80.7K
KRON
988
DELISTED
Kronos Bio
KRON
$336K 0.01%
258,775
+180,975
+233% +$292K
CLPT icon
989
ClearPoint Neuro
CLPT
$433M
$336K 0.01%
+66,992
New +$399K
LVOX
990
DELISTED
LiveVox Holding, Inc. Class A Common Stock
LVOX
$334K 0.01%
100,000
-20,000
-17% -$61.5K
GRTS
991
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$334K 0.01%
193,900
– –
PASG icon
992
Passage Bio
PASG
$14.1M
$333K 0.01%
25,330
+5,850
+30% +$96.1K
SUP
993
DELISTED
Superior Industries International
SUP
$333K 0.01%
109,600
– –
ABSI icon
994
Absci
ABSI
$1.51B
$333K 0.01%
252,000
+12,400
+5% +$21.7K
BBLU icon
995
EA Bridgeway Blue Chip ETF
BBLU
$461M
$332K 0.01%
34,652
– –
SCOR icon
996
Comscore
SCOR
$109M
$331K 0.01%
26,931
+545
+2% +$7.7K
HNST icon
997
The Honest Company
HNST
$586M
$330K 0.01%
262,000
+202,500
+340% +$297K
IPSC icon
998
Century Therapeutics
IPSC
$361M
$330K 0.01%
165,000
– –
ZIMV
999
DELISTED
ZimVie
ZIMV
$329K 0.01%
35,000
– –
OMER icon
1000
Omeros
OMER
$959M
$319K 0.01%
109,200
– –
38 39
40
41 42

Similar funds

SNT
SIG North Trading Bala Cynwyd, Pennsylvania $4.98B AUM 36.24% 1-Year Est. Return
MA
Marshfield Associates Washington, District of Columbia $4.99B AUM 1.59% 1-Year Est. Return
FFB
First Financial Bankshares Abilene, Texas $4.95B AUM 25.06% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return
SGM
Skye Global Management West Palm Beach, Florida $5B AUM 11.9% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
SMFG
Sumitomo Mitsui Financial Group Tokyo, Japan $4.94B AUM 1.39% 1-Year Est. Return
SIA
Sit Investment Associates Minneapolis, Minnesota $4.93B AUM 12.22% 1-Year Est. Return

Bridgeway Capital Management's Q3 2023 Portfolio in Review

As of Q3 2023, Bridgeway Capital Management held 1,475 positions worth $4.12B, down 1.3% from $4.18B the previous quarter. Its ten largest holdings account for 6.4% of the portfolio.

Bridgeway Capital Management's Q3 2023 filing shows 99 new, 592 increased, 300 reduced and 114 closed positions. Its largest new stake was Vir Biotechnology: 1,345,635 shares worth $12.6M. The largest sale was Boise Cascade, an estimated $17.7M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Bridgeway Capital Management's largest Q3 2023 buy was Vir Biotechnology: 1,345,635 shares worth $12.6M.
  • Bridgeway Capital Management added most to Oracle in Q3 2023, an estimated $12.4M increase.
  • Bridgeway Capital Management's biggest Q3 2023 reduction was Boise Cascade, cutting an estimated $17.7M.
  • Bridgeway Capital Management fully exited Treehouse Foods in Q3 2023, selling an estimated $11.5M.
  • Bridgeway Capital Management's ten largest holdings make up 6.4% of its $4.12B portfolio in Q3 2023.
  • Bridgeway Capital Management opened 99 new positions and closed 114 in Q3 2023.
  • Bridgeway Capital Management's portfolio value fell 1.3% quarter-over-quarter to $4.12B.

Based on Bridgeway Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.